Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Entero Therapeutics ( (ENTO) ) has provided an update.
On October 17, 2025, the stockholders of GridAI Corp waived their right to appoint two directors to Entero Therapeutics, Inc.’s Board of Directors. This decision will remain in effect until the shareholders of Entero Therapeutics approve the appointment of such directors at a future meeting, impacting the company’s governance structure.
More about Entero Therapeutics
Average Trading Volume: 1,820,766
Technical Sentiment Signal: Hold
Current Market Cap: $6.45M
For an in-depth examination of ENTO stock, go to TipRanks’ Overview page.